JP2017184729A5 - - Google Patents

Download PDF

Info

Publication number
JP2017184729A5
JP2017184729A5 JP2017046859A JP2017046859A JP2017184729A5 JP 2017184729 A5 JP2017184729 A5 JP 2017184729A5 JP 2017046859 A JP2017046859 A JP 2017046859A JP 2017046859 A JP2017046859 A JP 2017046859A JP 2017184729 A5 JP2017184729 A5 JP 2017184729A5
Authority
JP
Japan
Prior art keywords
expression
pde4d7
prostate cancer
sample
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017046859A
Other languages
English (en)
Japanese (ja)
Other versions
JP6430560B2 (ja
JP2017184729A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017184729A publication Critical patent/JP2017184729A/ja
Publication of JP2017184729A5 publication Critical patent/JP2017184729A5/ja
Application granted granted Critical
Publication of JP6430560B2 publication Critical patent/JP6430560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017046859A 2009-05-12 2017-03-13 前立腺癌マーカーとしてのホスホジエステラーゼ4d7 Active JP6430560B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159960 2009-05-12
EP09159960.5 2009-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012510424A Division JP6148007B2 (ja) 2009-05-12 2010-05-11 前立腺癌マーカーとしてのホスホジエステラーゼ4d7

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018205900A Division JP2019059733A (ja) 2009-05-12 2018-10-31 前立腺癌マーカーとしてのホスホジエステラーゼ4d7

Publications (3)

Publication Number Publication Date
JP2017184729A JP2017184729A (ja) 2017-10-12
JP2017184729A5 true JP2017184729A5 (https=) 2018-02-08
JP6430560B2 JP6430560B2 (ja) 2018-11-28

Family

ID=40843709

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012510424A Active JP6148007B2 (ja) 2009-05-12 2010-05-11 前立腺癌マーカーとしてのホスホジエステラーゼ4d7
JP2015188247A Active JP6105012B2 (ja) 2009-05-12 2015-09-25 前立腺癌マーカーとしてのホスホジエステラーゼ4d7
JP2017046859A Active JP6430560B2 (ja) 2009-05-12 2017-03-13 前立腺癌マーカーとしてのホスホジエステラーゼ4d7
JP2018205900A Pending JP2019059733A (ja) 2009-05-12 2018-10-31 前立腺癌マーカーとしてのホスホジエステラーゼ4d7

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012510424A Active JP6148007B2 (ja) 2009-05-12 2010-05-11 前立腺癌マーカーとしてのホスホジエステラーゼ4d7
JP2015188247A Active JP6105012B2 (ja) 2009-05-12 2015-09-25 前立腺癌マーカーとしてのホスホジエステラーゼ4d7

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018205900A Pending JP2019059733A (ja) 2009-05-12 2018-10-31 前立腺癌マーカーとしてのホスホジエステラーゼ4d7

Country Status (10)

Country Link
US (1) US8753892B2 (https=)
EP (2) EP3434787B1 (https=)
JP (4) JP6148007B2 (https=)
KR (1) KR101778036B1 (https=)
CN (2) CN107267482A (https=)
BR (1) BRPI1007093A2 (https=)
DK (1) DK2430191T3 (https=)
ES (1) ES2700877T3 (https=)
RU (1) RU2651474C2 (https=)
WO (1) WO2010131195A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3343647B2 (ja) 1997-07-22 2002-11-11 株式会社岡田建築デザインルーム 木造軸組在来構法による既存建物を、外部より鋼製受け梁と鋼製筋かいフレームにより耐震補強をなす架構
ES2707598T3 (es) * 2009-05-12 2019-04-04 Koninklijke Philips Nv Fosfodiesterasa 4D7 como marcador para cáncer maligno de próstata sensible a hormonas
ES2700877T3 (es) * 2009-05-12 2019-02-19 Koninklijke Philips Nv Fosfodiesterasa 4D7 como marcador de cáncer de próstata
KR20130088743A (ko) 2010-04-13 2013-08-08 갠 시스템즈 인크. 아일랜드 토폴로지를 이용한 고밀도 질화 갈륨 디바이스
GB201322034D0 (en) 2013-12-12 2014-01-29 Almac Diagnostics Ltd Prostate cancer classification
GB201504763D0 (en) 2015-03-20 2015-05-06 Mironid Ltd Compounds and uses
WO2016193110A1 (en) 2015-05-29 2016-12-08 Koninklijke Philips N.V. Methods of prostate cancer prognosis
CN105893782A (zh) * 2016-05-26 2016-08-24 江苏省人民医院 前列腺癌风险预测装置
GB201616439D0 (en) 2016-09-28 2016-11-09 Mironid Limited Compounds and uses
CN106544430A (zh) * 2016-11-04 2017-03-29 叶伟亮 一种检测前列腺癌的分子标记物及其应用
RU2766885C2 (ru) * 2016-12-01 2022-03-16 Конинклейке Филипс Н.В. Оценки риска на основе экспрессии варианта 7 фосфодиэстеразы 4d человека
EP3450981A1 (en) * 2017-08-28 2019-03-06 Trizell GmbH Btnl8 as a marker for tregs
ES2987603T3 (es) * 2017-11-03 2024-11-15 Oxford BioDynamics PLC Regulación genética de la respuesta inmunitaria por interacciones cromosómicas
DE102017125780B3 (de) * 2017-11-05 2018-12-13 Dimo Dietrich Verfahren zur Bestimmung des Ansprechens einer malignen Erkrankung auf eine Immuntherapie
KR102080887B1 (ko) * 2017-11-07 2020-02-24 고려대학교 산학협력단 Gcc2 유전자 또는 단백질을 과발현하는 엑소좀 기반 폐암 진단 또는 예후 예측용 마커 조성물
WO2019158825A1 (en) * 2018-02-16 2019-08-22 Tampereen Korkeakoulusäätiö SR Xrcc5 as biomarker for prostate cancer
GB201805527D0 (en) 2018-04-04 2018-05-16 Mironid Ltd Compounds and their use as pde4 activators
KR20220008175A (ko) * 2020-07-13 2022-01-20 가톨릭대학교 산학협력단 전립선암 환자의 예후 진단 및 치료 전략 결정용 병리등급 특이적 마커
CN112779348B (zh) * 2020-12-31 2022-05-20 四川农业大学 一种小麦单位面积穗数主效qtl位点及紧密连锁的kasp引物和应用
EP4608430A1 (en) 2022-10-27 2025-09-03 Koninklijke Philips N.V. Treatment of prostate cancer by promoting pde4d7
EP4360711A1 (en) * 2022-10-27 2024-05-01 Koninklijke Philips N.V. Treatment of prostate cancer by promoting pde4d7
EP4600377A1 (en) 2024-02-12 2025-08-13 Koninklijke Philips N.V. Prediction of an outcome of a subject suffering from a glioma
CN121548649A (zh) 2023-07-18 2026-02-17 皇家飞利浦有限公司 预测患有神经胶质瘤的受试者的结果
EP4620461A1 (en) 2024-03-22 2025-09-24 Koninklijke Philips N.V. Treatment of prostate cancer by inhibiting short pde4d isoforms
EP4722388A1 (en) 2024-10-03 2026-04-08 Koninklijke Philips N.V. Prediction of an outcome of a subject suffering from acute myoloid leukemia

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932465A (en) * 1997-10-16 1999-08-03 Icos Corporation Phosphodiesterase 8A
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
IL156413A0 (en) * 2001-01-31 2004-01-04 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
IS7221A (is) * 2001-11-15 2004-04-15 Memory Pharmaceuticals Corporation Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra
US20030220273A1 (en) * 2002-05-15 2003-11-27 Isis Pharmaceuticals Inc. Antisense modulation of phosphodiesterase 4D expression
AU2003301894A1 (en) * 2002-11-08 2004-06-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
AU2003283303A1 (en) 2002-11-08 2004-06-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
EP1426767A1 (en) 2002-12-04 2004-06-09 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (PDE4C)
CA2458085A1 (en) * 2003-03-21 2004-09-21 F. Hoffmann-La Roche Ag Transcriptional activity assay
AU2004227089A1 (en) * 2003-04-10 2004-10-21 Decode Genetics Ehf. The use of PDE4D in the screening for medicaments against atherosclerosis
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
WO2007134451A1 (en) * 2006-05-19 2007-11-29 Topigen Pharmaceuticals Inc. Oligonucleotides affecting expression of phosphodiesterases
US9939441B2 (en) * 2006-07-21 2018-04-10 Epigenomics Ag Methods and nucleic acids for analyses for cellular proliferative disorders
EP2837697B1 (en) 2006-10-10 2016-12-07 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Prostate cancer-specific alterations in ERG gene expression and detection methods based on those alternations
WO2009065511A2 (en) * 2007-11-23 2009-05-28 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
ES2707598T3 (es) * 2009-05-12 2019-04-04 Koninklijke Philips Nv Fosfodiesterasa 4D7 como marcador para cáncer maligno de próstata sensible a hormonas
ES2700877T3 (es) * 2009-05-12 2019-02-19 Koninklijke Philips Nv Fosfodiesterasa 4D7 como marcador de cáncer de próstata
US9279750B2 (en) * 2013-03-15 2016-03-08 Iris International, Inc. Method and composition for staining and sample processing

Similar Documents

Publication Publication Date Title
JP2017184729A5 (https=)
JP6630766B2 (ja) 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法
JP2012526544A5 (https=)
US10408839B2 (en) Biomarker panel for diagnosing cancer
Wu et al. PD-L1 detection on circulating tumor-derived extracellular vesicles (T-EVs) from patients with lung cancer
RU2016134839A (ru) Биомаркер и способы для ранней диагностики болезни альцгеймера
JP6983221B2 (ja) 大腸癌の併用検査
WO2012129325A1 (en) Molecular analysis of tumor samples
US20210310080A1 (en) Composition for diagnosing cancer using potassium channel proteins
JP6415546B2 (ja) 脳卒中の鑑別診断を支援する方法
US20160003786A1 (en) Methods Of Detecting Cancer
Xu et al. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma
AU2012343537B2 (en) Biomarker-based methods and biochips for aiding the diagnosis of stroke
JP2012526543A5 (https=)
JP6361943B2 (ja) 補体因子bタンパク質に特異的に結合する抗体及び糖鎖抗原19−9タンパク質に特異的に結合する抗体を含む膵臓癌診断用キット
KR20180088840A (ko) 마커 사람 부고환 단백질 4 (he4) 기반의 폐 선암 재발의 발견 방법 및 관련 용도
EP3428648B1 (en) Method for assisting prediction of recurrence risk in hepatocellular carcinoma patient, and use of a kit
EP3215851B1 (en) Lung cancer sub-typing method
WO2016143805A1 (ja) 膀胱がんの検出方法
JP7046394B2 (ja) グリオーマ検出用バイオマーカー
JP2015078842A (ja) 虚血性心疾患の評価方法、評価用キット及び評価装置
la Brzobohatá et al. BIOM-37. EV-TRACK: EXTRACELLULAR VESICLE PROFILING FOR NON-INVASIVE GLIOBLASTOMA DIAGNOSIS AND MONITORING
AU2018100578A4 (en) Method for detection & diagnosis of oral cancer in a sample
JP7126668B2 (ja) 膠原病判定方法
WO2021245413A1 (en) Methods of determining cancer